COMBO dual-therapy stent: non-inferior to drug-eluting stents or stepping back to bare metal stents?
- PMID: 29982320
- DOI: 10.1093/eurheartj/ehy351
COMBO dual-therapy stent: non-inferior to drug-eluting stents or stepping back to bare metal stents?
Comment on
-
Japan-United States of America Harmonized Assessment by Randomized Multicentre Study of OrbusNEich's Combo StEnt (Japan-USA HARMONEE) study: primary results of the pivotal registration study of combined endothelial progenitor cell capture and drug-eluting stent in patients with ischaemic coronary disease and non-ST-elevation acute coronary syndrome.Eur Heart J. 2018 Jul 7;39(26):2460-2468. doi: 10.1093/eurheartj/ehy275. Eur Heart J. 2018. PMID: 29931092 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
